Consolidated Statutes and Regulations Consolidated Statutes Consolidated Regulations Annual Statutes and Regulations Annual Statutes Annual Regulations Additional information Québec Official Publisher What’s new? Information note Policy of the Minister of Justice Laws: Amendments Laws: Provisions not in force Laws: Provisions brought into force Annual Statutes: PDF versions since 1996 Regulations: Amendments Annual Regulations: PDF versions since 1996 Court Decisions

A-6.001, r. 6.1 - Regulation respecting the fees payable to the Institut national d’excellence en santé et en services sociaux for the scientific evaluation of a drug, stable blood product or technology for listing purposes

Section 1
Disposition versions

Full text
1. A manufacturer who asks the Institut national d’excellence en santé et en services sociaux to conduct a scientific evaluation of a drug, stable blood product or technology shall pay the fees set out in Schedule 1.
These fees vary according to the scientific evaluation that the Institut decides to conduct after receiving the request from the manufacturer and determining its eligibility for scientific evaluation.
O.C. 861-2018, s. 1; O.C. 770-2021, s. 2.
1. A manufacturer who asks the Institut national d’excellence en santé et en services sociaux to conduct a scientific evaluation of a drug or a stable blood product shall pay the fees set out in Schedule 1.
These fees vary according to the scientific evaluation that the Institut decides to conduct after receiving the request from the manufacturer.
O.C. 861-2018, s. 1.
In force: 2018-07-19
1. A manufacturer who asks the Institut national d’excellence en santé et en services sociaux to conduct a scientific evaluation of a drug or a stable blood product shall pay the fees set out in Schedule 1.
These fees vary according to the scientific evaluation that the Institut decides to conduct after receiving the request from the manufacturer.
O.C. 861-2018, s. 1.
© Gouvernement du Québec